Dizal Reveals New Findings from Biomarker Analysis, Highlighting Sunvozertinib as an Effective Treatment for Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
PR Newswire Asia
· Anittumor efficacy of sunvozertinib was observed in patients regardless of baseline EGFR exon20ins status in plasma..